Fox News cut Maria Bartiromo to trim a legal liability
By Elena Rossi ·
By Elena Rossi ·
The kind of economic optimism being peddled out of Beijing right now smells like cheap disinfectant—a desperate attempt to scrub away the stench of structural failure.
By Josie Calloway ·
The corporate class has perfected the art of the optimistic press release—a carefully curated narrative designed to convince investors that the headwinds they themselves created…
By Emilio Quesada ·
It is always the periphery that feels the squeeze first. We are told this AI boom—this colossal race to build computational gods—is merely an investment cycle, a necessary cost of progress.
By Aoife Gallagher ·
The numbers, presented by CNBC, straitstimes.com, and ca.finance.yahoo.com alike, paint a picture of robust Chinese trade performance for July. Exports surged 23.9% year-on-year in U.S.
By Emilio Quesada ·
The market’s reaction to AMD’s Q2 earnings was less a correction and more a violent reminder of how much we are still operating on pure narrative hype.
By Maya Ellison ·
When you are poor—when your labor barely covers rent—you don't worry about optimizing your gut microbiome or achieving peak cognitive function by taking a handful of expensive pills.
By Alma Cordero ·
The language they use is always so clean: "optimization," "enhanced reach," "smaller format." Jason Bonfig, incoming Best Buy CEO, pitches this shift as a triumph of vision,…
By Alma Cordero ·
The predictable theater of American protectionism has once again opened its curtain.
By Emilio Quesada ·
Members of both chambers of Congress moved on Thursday, July 23, 2026, passing resolutions that restricted executive power and sought accountability for the ongoing hostilities in Iran.
By Alma Cordero ·
Donald Trump plans to impose steep, escalating tariffs on imported generic drugs from outside the U.S., detailing a structured schedule that aims to reshape pharmaceutical manufacturing within American borders.
By Ruth Behrens ·